In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...
Andrew Witty
Andrew Witty became CEO of UnitedHealth Group in 2021, but this isn’t his first medical executive gig—he also served as CEO ...
The KSE-100 index of Pakistan Stock Exchange (PSX) lost on Tuesday more than 400 points, weighed down by institutional profit ...
Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
Other notable outperformers include FDC (9.5%), Eris Lifesciences Ltd. (8.6%), Alkem Laboratories Ltd. (7.2%), Abbott India ...
GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...
The Pakistani Rupee has slipped against the US Dollar, with the exchange rate showing a slight decline in intra-day trading. The USD is trading at Rs277.80 in in the interbank market during intra-day ...
Constellation Energy has applied to reopen a nuclear power plant on Three Mile Island in the Susquehanna — not the one shut after a coolant failure in 1979, but its long-running neighbor, closed by ...
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...